Nektar Therapeutics reported $85.2M in Current Liabilities for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 59.83M 1.93M
Eisai 4523:JP Y 304993M 24164M
Immunogen IMGN:US $ 84.12M 16.83M
IONIS PHARMACEUT IONS:US $ 241M 38.78M
Ironwood Pharmaceuticals IRWD:US $ 147.4M 14.3M
Mirati Therapeutics MRTX:US $ 123.57M 20.09M
Nektar Therapeutics NKTR:US $ 85.2M 54.77M
Novartis NOVN:VX SF 30208M 328M
Teva Pharmaceutical TEVA:IT 11.03B 798M
Xencor XNCR:US $ 60.94M 9.8M